Dissecting the immune infiltrate of primary luminal B‐like breast carcinomas in relation to age
Authors:
Open Access
- 29 September 2024
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 264 (3) , 344-356
Abstract
The impact of aging on the immune landscape of luminal breast cancer (Lum‐BC) is poorly characterized. Understanding the age‐related dynamics of immune editing in Lum‐BC is anticipated to improve the therapeutic benefit of immunotherapy in older patients. To this end, here we applied the ‘multiple iterative labeling by antibody neo‐deposition’ (MILAN) technique, a spatially resolved single‐cell multiplex immunohistochemistry method. We created tissue microarrays by sampling both the tumor center and invasive front of luminal breast tumors collected from a cohort of treatment‐naïve patients enrolled in the prospective monocentric IMAGE (IMmune system and AGEing) study. Patients were subdivided into three nonoverlapping age categories (35–45 = ‘young’, n = 12; 55–65 = ‘middle’, n = 15; ≥70 = ‘old’, n = 26). Additionally, depending on localization and amount of cytotoxic T lymphocytes, the tumor immune types ‘desert’ (n = 22), ‘excluded’ (n = 19), and ‘inflamed’ (n = 12) were identified. For the MILAN technique we used 58 markers comprising phenotypic and functional markers allowing in‐depth characterization of T and B lymphocytes (T&B‐lym). These were compared between age groups and tumor immune types using Wilcoxon's test and Pearson's correlation. Cytometric analysis revealed a decline of the immune cell compartment with aging. T&B‐lym were numerically less abundant in tumors from middle‐aged and old compared to young patients, regardless of the geographical tumor zone. Likewise, desert‐type tumors showed the smallest immune‐cell compartment and were not represented in the group of young patients. Analysis of immune checkpoint molecules revealed a heterogeneous geographical pattern of expression, indicating higher numbers of PD‐L1 and OX40‐positive T&B‐lym in young compared to old patients. Despite the numerical decline of immune infiltration, old patients retained higher expression levels of OX40 in T helper cells located near cancer cells, compared to middle‐aged and young patients. Aging is associated with important numerical and functional changes of the immune landscape in Lum‐BC. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.Keywords
This publication has 53 references indexed in Scilit:
- LBA21 KEYNOTE-756: Phase III study of neoadjuvant pembrolizumab (pembro) or placebo (pbo) + chemotherapy (chemo), followed by adjuvant pembro or pbo + endocrine therapy (ET) for early-stage high-risk ER+/HER2– breast cancerAnnals of Oncology, 2023
- LBA20 A randomized, double-blind trial of nivolumab (NIVO) vs placebo (PBO) with neoadjuvant chemotherapy (NACT) followed by adjuvant endocrine therapy (ET) ± NIVO in patients (pts) with high-risk, ER+ HER2− primary breast cancer (BC)Annals of Oncology, 2023
- Differential distribution of actual and surrogate oncotype DX recurrence scores in breast cancer patients by age, menopausal status, race, and body mass indexBreast Cancer Research and Treatment, 2023
- Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?Current Treatment Options in Oncology, 2023
- Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancerClinical & Translational Immunology, 2020
- T Cell Dysfunction in CancerCancer Cell, 2018
- FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry dataCytometry Part A, 2015
- Age and Cancer RiskAmerican Journal of Preventive Medicine, 2014
- Are People Aware of Oral and Maxillofacial Surgery in India?Journal of Maxillofacial and Oral Surgery, 2011
- The effect of aging on OX40 agonist-mediated cancer immunotherapyCancer Immunology, Immunotherapy, 2009